Inovio Pharmaceuticals Inc. Stock Rallies 6.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rallied 6.9% to $0.90 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 25,955.34 and Dow Jones Industrial Average falling 1.2% to 52,215.16.

This was the stock's second consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 67.0% short of its 52-week high of $2.72, which the company achieved on December 17th.

The stock outperformed some of its peers, as Johnson & Johnson fell 1.4% to $263.81, Statera Biopharma Inc. fell 50.0% to $0.00, and Pfizer Inc. fell 1.28% to $30.03.

Trading volume totaled 3.9 million, compared to the 50-day average of 4.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 23, 2026 16:33 ET (20:33 GMT)